InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,652.00
(
0.06%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,777.86
(
-0.03%
)
Post# of 239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

zino

Send PM Follow Ignore
Followers 335
Posts 19013
Boards Moderated 0
Alias Born 08/25/2007

zino

Re: ©PROPHETABLE post# 87

Monday, 06/19/2017 10:44:39 AM

Monday, June 19, 2017 10:44:39 AM

Post# of 239
MSDI... Larazotide has received FDA Fast Track
prepare for phase 3 clinical trials for larazotide in celiac disease later this year. Larazotide is the only drug which has successfully met its primary endpoint in an efficacy clinical trial for celiac disease.
http://www.innovatebiopharma.com/PressReleases_6June2017.html

DONT LISTEN TO ME IM CANADIANNNNNNNN

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up